InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Arcutis Biotherapeutics, Inc.

ARQT Clue Score48
United States Fiscal year ends December CIK 0001787306 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

50
Insider
Date
Role
Action
Shares
Price
Amount
Masaru Matsuda
2 Nov 2026
EVP, Chief Legal Officer
Sold on a plan
1,219
$31.86
$38.84K
Masaru Matsuda
16 Sep 2026
See Remarks
Sold on a plan
3,674
$25.00
$91.85K
Masaru Matsuda
8 Sep 2026
See Remarks
Sold on a plan
9,989
$25.03
$249.99K
Todd Watanabe
3 Aug 2026
See Remarks
Sold on a plan
4,375
$26.12
$114.26K
Masaru Matsuda
3 Aug 2026
See Remarks
Sold on a plan
1,230
$26.12
$32.12K
Patrick Burnett
3 Aug 2026
See Remarks
Sold on a plan
955
$26.12
$24.94K
Howard G. Welgus
17 Jun 2026
Director
Sold on a plan
635
$25.67
$16.30K
Sue-Jean Lin
15 Jun 2026
Director
Sold on a plan
4,946
$24.38
$120.59K
Patrick Burnett
11 May 2026
See Remarks
Sold on a plan
222
$21.05
$4.67K
Latha Vairavan
11 May 2026
SVP Chief Financial Officer
Sold on a plan
435
$21.05
$9.16K
Todd Watanabe
4 May 2026
See Remarks
Sold on a plan
3,172
$23.61
$74.89K
Latha Vairavan
4 May 2026
SVP Chief Financial Officer
Sold on a plan
1,341
$23.61
$31.66K
Patrick Burnett
4 May 2026
See Remarks
Sold on a plan
684
$23.61
$16.15K
Masaru Matsuda
4 May 2026
See Remarks
Sold on a plan
884
$23.61
$20.87K
Masaru Matsuda
4 May 2026
See Remarks
Sold on a plan
7,372
$23.27
$171.54K
Howard G. Welgus
1 May 2026
Director
Sold on a plan
7,144
$22.99
$164.22K
Howard G. Welgus
1 Apr 2026
Director
Sold on a plan
10,000
$23.88
$238.80K
Patrick Burnett
2 Mar 2026
See Remarks
Sold on a plan
181
$25.91
$4.69K
Patrick Burnett
2 Mar 2026
See Remarks
Sold on a plan
6,106
$25.16
$153.63K
Latha Vairavan
2 Mar 2026
SVP Chief Financial Officer
Sold on a plan
81
$25.91
$2.10K
Latha Vairavan
2 Mar 2026
SVP Chief Financial Officer
Sold on a plan
2,772
$25.16
$69.74K
Masaru Matsuda
2 Mar 2026
See Remarks
Sold on a plan
1,987
$25.70
$51.07K
Masaru Matsuda
2 Mar 2026
See Remarks
Sold on a plan
193
$25.91
$5.00K
Masaru Matsuda
2 Mar 2026
See Remarks
Sold on a plan
6,553
$25.16
$164.88K
Todd Watanabe
2 Mar 2026
See Remarks
Sold on a plan
1,068
$25.91
$27.68K
Todd Watanabe
2 Mar 2026
See Remarks
Sold on a plan
36,281
$25.16
$912.85K
Larry Todd Edwards
2 Mar 2026
See Remarks
Sold on a plan
103
$25.91
$2.67K
Larry Todd Edwards
2 Mar 2026
See Remarks
Sold on a plan
3,584
$25.16
$90.18K
Howard G. Welgus
2 Mar 2026
Director
Sold on a plan
10,000
$25.65
$256.52K
Masaru Matsuda
27 Feb 2026
See Remarks
Sold on a plan
3,325
$27.95
$92.93K
Patrick Burnett
4 Feb 2026
See Remarks
Sold on a plan
9,794
$25.81
$252.75K
Larry Todd Edwards
2 Feb 2026
See Remarks
Sold on a plan
2,052
$25.50
$52.32K
Howard G. Welgus
2 Feb 2026
Director
Sold on a plan
10,000
$25.05
$250.48K
Latha Vairavan
2 Feb 2026
SVP Chief Financial Officer
Sold on a plan
1,320
$25.50
$33.66K
Todd Watanabe
2 Feb 2026
See Remarks
Sold on a plan
19,833
$25.50
$505.71K
Patrick Burnett
2 Feb 2026
See Remarks
Sold on a plan
3,675
$25.50
$93.71K
Masaru Matsuda
2 Feb 2026
See Remarks
Sold on a plan
4,714
$25.63
$120.82K
Masaru Matsuda
2 Feb 2026
See Remarks
Sold on a plan
19,379
$25.24
$489.13K
Masaru Matsuda
2 Feb 2026
See Remarks
Sold on a plan
8,562
$24.97
$213.79K
Masaru Matsuda
2 Feb 2026
See Remarks
Sold on a plan
7,983
$25.50
$203.55K
Patrick Burnett
5 Jan 2026
See Remarks
Sold on a plan
2,490
$28.98
$72.17K
Howard G. Welgus
2 Jan 2026
Director
Sold on a plan
10,000
$28.96
$289.61K
Patrick Burnett
31 Dec 2025
See Remarks
Sold on a plan
1,156
$29.39
$33.97K
Patrick Burnett
31 Dec 2025
See Remarks
Sold on a plan
541
$28.81
$15.59K
Howard G. Welgus
1 Dec 2025
Director
Sold on a plan
10,000
$30.21
$302.13K
Masaru Matsuda
1 Dec 2025
See Remarks
Sold on a plan
1,657
$30.23
$50.09K
Todd Watanabe
24 Nov 2025
See Remarks
Sold on a plan
48,945
$30.36
$1.49M
Todd Watanabe
21 Nov 2025
See Remarks
Sold on a plan
1,055
$30.00
$31.65K
Masaru Matsuda
19 Nov 2025
See Remarks
Sold on a plan
1,561
$28.50
$44.49K
Masaru Matsuda
19 Nov 2025
See Remarks
Sold on a plan
989
$27.95
$27.65K
Show all 72 transactions →

What was left out

Form 4 filings counted 64
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 50
Sales straight out of an exercise 18
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 545,227
History held since 3 Feb 2020